PETMED EXPRESS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
PETMED EXPRESS, INC. (PETS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 118.00 thousand shares for the 12-month period ending 2023-03-31, per its 10-K/A filed 2024-04-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2024-04-15
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 118.00K shares, a 19.19% increase from fiscal 2022.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 99.00K shares, a 21.43% decline from fiscal 2021.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2021 was 126.00K shares, a 72.60% increase from fiscal 2020.
- PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2020 was 73.00K shares, a 37.07% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|
| 2023-03-31 | 118.00K shares 10-K/A · filed 2024-04-15 |
| 2022-03-31 | 99.00K shares 10-K · filed 2022-05-24 |
| 2021-03-31 | 126.00K shares 10-K · filed 2021-05-25 |
| 2020-03-31 | 73.00K shares 10-K · filed 2020-05-26 |
| 2019-03-31 | 116.00K shares 10-K · filed 2019-05-28 |
| 2018-03-31 | 114.00 shares 10-K · filed 2018-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |